UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.807

Sortiert nach

Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer

Oncogene, 2011-11, Vol.30 (47), p.4697-4706

2011

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

JNCI : Journal of the National Cancer Institute, 2001-05, Vol.93 (9), p.691-699

2001

Link zum Volltext

Verfügbarkeit prüfen

Hypoxic repression of STAT1 and its downstream genes by a pVHL HIF-1 target DEC1 STRA13

Oncogene, 2007-02, Vol.26 (6), p.802-812

2007

Link zum Volltext

Verfügbarkeit prüfen

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter

Oncogene, 2007-07, Vol.26 (31), p.4499-4512

2007

Link zum Volltext

Verfügbarkeit prüfen

High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (7), p.1949-1960

2000

Link zum Volltext

Verfügbarkeit prüfen

Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma

Journal of medical genetics, 2003-04, Vol.40 (4), p.257-261

2003

Link zum Volltext

Verfügbarkeit prüfen

Silencing of the VHL Tumor-Suppressor Gene by DNA Methylation in Renal Carcinoma

Proceedings of the National Academy of Sciences - PNAS, 1994-10, Vol.91 (21), p.9700-9704

1994

Link zum Volltext

Verfügbarkeit prüfen

Mutations of the VHL tumour suppressor gene in renal carcinoma

Nature genetics, 1994-05, Vol.7 (1), p.85-90

1994

Link zum Volltext

Verfügbarkeit prüfen

Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer

JAMA : the journal of the American Medical Association, 1995-02, Vol.273 (7), p.564

1995

Link zum Volltext

Verfügbarkeit prüfen

STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker

Journal of medical genetics, 2005-07, Vol.42 (7), p.565-576

2005

Link zum Volltext

Verfügbarkeit prüfen

STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets

Journal of molecular biology, 2004-07, Vol.340 (4), p.641-653

2004

Link zum Volltext

Verfügbarkeit prüfen

Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours

The Journal of pathology, 2008, Vol.214 (1), p.46-57

2008

Link zum Volltext

Verfügbarkeit prüfen

Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter

Journal of medical genetics, 2002-07, Vol.39 (7), p.463-472

2002

Link zum Volltext

Verfügbarkeit prüfen

Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene

Oncogene, 1998-06, Vol.16 (24), p.3151-3157

1998

Link zum Volltext

Verfügbarkeit prüfen

Identification of intragenic mutations in the Von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype

Human molecular genetics, 1994-08, Vol.3 (8), p.1303-1308

1994

Link zum Volltext

Verfügbarkeit prüfen

Human Semaphorins A(V) and IV Reside in the 3p21.3 Small Cell Lung Cancer Deletion Region and Demonstrate Distinct Expression Patterns

Proceedings of the National Academy of Sciences - PNAS, 1996-04, Vol.93 (9), p.4120-4125

1996

Link zum Volltext

Verfügbarkeit prüfen

Cellular proteins that bind the von Hippel-Lindau disease gene product : mapping of binding domains and the effect of missense mutations

Cancer research (Chicago, Ill.), 1995-10, Vol.55 (20), p.4544-4548

1995

Link zum Volltext

Verfügbarkeit prüfen

Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3 : Progress toward the isolation of a lung cancer TSG

Cancer research (Chicago, Ill.), 1996-04, Vol.56 (7), p.1487-1492

1996

Link zum Volltext

Verfügbarkeit prüfen

Distinct Hypermethylation Patterns Occur at Altered Chromosome Loci in Human Lung and Colon Cancer

Proceedings of the National Academy of Sciences - PNAS, 1992-03, Vol.89 (5), p.1929-1933

1992

Link zum Volltext

Verfügbarkeit prüfen

Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease

Science (American Association for the Advancement of Science), 1987-02, Vol.235 (4791), p.877-880

1987

Link zum Volltext

Verfügbarkeit prüfen

In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules

Human genetics, 1998-09, Vol.103 (3), p.355-364

1998

Link zum Volltext

Verfügbarkeit prüfen

Candidate Tumor Suppressor HYAL2 is a Glycosylphosphatidylinositol (GPI)-Anchored Cell-Surface Receptor for Jaagsiekte Sheep Retrovirus, the Envelope Protein of Which Mediates Oncogenic Transformation

Proceedings of the National Academy of Sciences - PNAS, 2001-04, Vol.98 (8), p.4443-4448

2001

Link zum Volltext

Verfügbarkeit prüfen

Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany : evidence for a founder effect

Human genetics, 1995-05, Vol.95 (5), p.551-556

1995

Link zum Volltext

Verfügbarkeit prüfen

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

Oncogene, 2001-03, Vol.20 (12), p.1509-1518

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.807

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.491)
Mit Volltextzugriff
(2.426)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.627)
Life Sciences & Biomedicine
(1.429)
Humans
(1.320)
Female
(829)
Male
(719)
Biological And Medical Sciences
(680)
Medical Sciences
(554)
Middle Aged
(455)
Cardiovascular System & Cardiology
(423)
Adult
(411)
Animals
(405)
Cardiac & Cardiovascular Systems
(369)
Aged
(326)
Child
(169)
Fundamental And Applied Biological Sciences. Psychology
(148)
Risk Factors
(143)
Physical Sciences
(142)
Treatment Outcome
(138)
Cardiology. Vascular System
(137)
Adolescent
(135)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer

Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

Hypoxic repression of STAT1 and its downstream genes by a pVHL HIF-1 target DEC1 STRA13

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter

High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints

Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma

Silencing of the VHL Tumor-Suppressor Gene by DNA Methylation in Renal Carcinoma

Mutations of the VHL tumour suppressor gene in renal carcinoma

Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer

STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker

STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets

Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours

Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter

Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene

Identification of intragenic mutations in the Von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype

Human Semaphorins A(V) and IV Reside in the 3p21.3 Small Cell Lung Cancer Deletion Region and Demonstrate Distinct Expression Patterns

Cellular proteins that bind the von Hippel-Lindau disease gene product : mapping of binding domains and the effect of missense mutations

Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3 : Progress toward the isolation of a lung cancer TSG

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

Distinct Hypermethylation Patterns Occur at Altered Chromosome Loci in Human Lung and Colon Cancer

Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease

In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules

Candidate Tumor Suppressor HYAL2 is a Glycosylphosphatidylinositol (GPI)-Anchored Cell-Surface Receptor for Jaagsiekte Sheep Retrovirus, the Envelope Protein of Which Mediates Oncogenic Transformation

Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany : evidence for a founder effect

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

Suchergebnisse filtern